Neurones (0GX2) Stock Statistics & Valuation Metrics
Total Valuation
Neurones has a market cap or net worth of EUR 907.21M. The enterprise value is EUR 631.41M.
- Market Cap
- EUR 907.21M
- Enterprise Value
- EUR 631.41M
Share Statistics
Neurones has 23,842,455 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 23,842,455
- Owned by Insiders
- ―
- Owned by Institutions
- 2.35%
Financial Efficiency
Neurones’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 10.62%.
- Return on Equity (ROE)
- 0.13
- Return on Assets (ROA)
- 0.07
- Return on Invested Capital (ROIC)
- 10.62%
- Return on Capital Employed (ROCE)
- 0.14
- Revenue Per Employee
- 116.96K
- Profits Per Employee
- 7,105.062
- Employee Count
- 7,329
- Asset Turnover
- 1.14
- Inventory Turnover
- 42618.50
Valuation Ratios
The current PE Ratio of Neurones is 16.69. Neurones’s PEG ratio is 1.84.
- PE Ratio
- 16.69
- PS Ratio
- 1.02
- PB Ratio
- 2.96
- Price to FCF
- 10.24
- Price to Operating Cash Flow
- 11.07
- PEG Ratio
- 1.84
Income Statement
In the last 12 months, Neurones had revenue of 857.20M and earned 52.07M in profits. Earnings per share was 2.14.
- Revenue
- 857.20M
- Gross Profit
- 90.04M
- Operating Income
- 72.33M
- Pretax Income
- 82.60M
- Net Income
- 52.07M
- EBITDA
- 90.32M
- Earnings Per Share (EPS)
- 2.14
Cash Flow
In the last 12 months, operating cash flow was 100.76M and capital expenditures -12.18M, giving a free cash flow of 88.59M billion.
- Operating Cash Flow
- 100.76M
- Free Cash Flow
- 88.59M
- Free Cash Flow per Share
- 3.02
Dividends & Yields
Neurones pays an annual dividend of EUR 1.40, resulting in a dividend yield of 3.68%
- Dividend Per Share
- EUR 1.40
- Dividend Yield
- 3.68%
- Payout Ratio
- 65.36%
- Free Cash Flow Yield
- 9.76%
- Earnings Yield
- 4.96%
Stock Price Statistics
- Beta
- 0.59
- 52-Week Price Change
- -4.04%
- 50-Day Moving Average
- 36.55
- 200-Day Moving Average
- 35.89
- Relative Strength Index (RSI)
- 58.38
- Average Volume (3m)
- 637
Important Dates
Neurones upcoming earnings date is Mar 10, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Sep 09, 2026
- Next Earnings Date
- Mar 10, 2027
- Ex-Dividend Date
- Jun 10, 2026
Financial Position
Neurones as a current ratio of 2.43, with Debt / Equity ratio of 9.24%
- Current Ratio
- 2.43
- Quick Ratio
- 2.43
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -3.36
- Interest Coverage Ratio
- 60.43
Taxes
In the past 12 months, Neurones has paid 20.75M in taxes.
- Income Tax
- 20.75M
- Effective Tax Rate
- 0.25
Enterprise Valuation
Neurones EV to EBITDA ratio is 6.71, with an EV/FCF ratio of 7.30.
- EV to Sales
- 0.73
- EV to EBITDA
- 6.71
- EV to Free Cash Flow
- 7.30
- EV to Operating Cash Flow
- 6.42
Balance Sheet
Neurones has EUR 301.88M in cash and marketable securities with EUR 41.30M in debt, giving a net cash position of EUR 260.58M billion.
- Cash & Marketable Securities
- EUR 301.88M
- Total Debt
- EUR 41.30M
- Net Cash
- EUR 260.58M
- Net Cash Per Share
- EUR 10.93
- Tangible Book Value Per Share
- EUR 12.65
Margins
Gross margin is 56.88%, with operating margin of 8.89%, and net profit margin of 6.23%.
- Gross Margin
- 56.88%
- Operating Margin
- 8.89%
- Pretax Margin
- 10.04%
- Net Profit Margin
- 6.23%
- EBITDA Margin
- 10.85%
- EBIT Margin
- 8.89%
Analyst Forecast
The average price target for Neurones is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 6.68%
- EPS Growth Forecast
- 9.16%